CHARLES SCHWAB INVESTMENT MANAGEMENT INC - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 92 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$186,000
-88.4%
217,621
-25.4%
0.00%
Q1 2022$1,609,000
-45.5%
291,877
-4.4%
0.00%
-100.0%
Q4 2021$2,955,000
-44.8%
305,266
+2.1%
0.00%
-50.0%
Q3 2021$5,349,000
-28.4%
299,122
-2.3%
0.00%0.0%
Q2 2021$7,471,000
+3.3%
306,047
+12.2%
0.00%
-33.3%
Q1 2021$7,229,000
+292.0%
272,791
+12.3%
0.00%
+200.0%
Q4 2020$1,844,000
+56.1%
242,925
+3.1%
0.00%0.0%
Q3 2020$1,181,000
-14.4%
235,622
+2.2%
0.00%0.0%
Q2 2020$1,380,000
+45.3%
230,655
+8.1%
0.00%0.0%
Q1 2020$950,000
-52.5%
213,436
+1.4%
0.00%0.0%
Q4 2019$2,000,000
+23.1%
210,493
+1.7%
0.00%0.0%
Q3 2019$1,625,000
-11.2%
206,994
+78.1%
0.00%0.0%
Q2 2019$1,829,000
-3.5%
116,221
+11.0%
0.00%0.0%
Q1 2019$1,896,000
+90.4%
104,715
+69.1%
0.00%0.0%
Q4 2018$996,000
-33.8%
61,913
-1.2%
0.00%0.0%
Q3 2018$1,504,00062,6530.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,296,526$290,671,0005.29%
HARBOURVEST PARTNERS LLC 986,878$7,490,0002.93%
Abbot Financial Management, Inc. 537,000$4,076,0002.35%
Artal Group S.A. 3,778,913$28,682,0000.62%
HITE Hedge Asset Management LLC 88,740$674,0000.16%
Virtus ETF Advisers LLC 33,793$256,0000.11%
JACOBS LEVY EQUITY MANAGEMENT, INC 394,909$2,997,0000.03%
Baillie Gifford 4,710,061$35,749,0000.02%
Caption Management, LLC 86,000$652,0000.02%
Blueshift Asset Management, LLC 14,626$111,0000.01%
View complete list of RUBIUS THERAPEUTICS INC shareholders